RecruitingNCT06534307

Long-term Follow-up of Children Born in the PETN Studies

Langzeiteffekt Einer Pentaerithrityltetranitrat (PETN)-Behandlung in Der Schwangerschaft - Nachbeobachtung Der Kinder Der PETN-Studien


Sponsor

Jena University Hospital

Enrollment

228 participants

Start Date

Jun 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

In every 10th pregnancy, the child in the uterus is insufficiently nourished, a so-called growth retardation. This occurs when the child cannot reach its growth potential due to an undersupply in the uterus. This inadequate supply is considered a developmental cause for the later development of physical diseases like cardiovascular diseases, sugar metabolism disorders and obesity as well as mental developmental problems (for example problems in cognitive skills, deficits in language development, concentration and attention). From 2002 to 2008, 111 patients with impaired placental blood flow were included in a small study and treated with Pentalong or placebo. From 2017 to 2022, the positive effects of the study treatment were tested on a larger number of patients. A total of 317 pregnant women were included at 14 participating study centers in Germany. In this follow-up study, the development of the children born in the two studies will be examined. The study consists of two independent parts: firstly, questionnaires are answered by the former participants and secondly, an on-site visit is carried out to check the physical and mental health of the child.


Eligibility

Min Age: 6 YearsMax Age: 18 Years

Inclusion Criteria4

  • mothers participation in one of the PETN studies
  • age above 5 years
  • completion of questionnaires for self reported data
  • written consent for physical examination

Exclusion Criteria1

  • physical and mental states preventing physical examination

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALQuestionnaire Child Behaviour Checklist

The Child Behavior Checklist comprises items assigned to 8 subscales describing various behavioral areas. These subscales can be summed up to scores for internalizing and externalizing problems as well as a total score. Checklist scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean higher amount of problems.

BEHAVIORALQuestionnaire Young Self Report

The Questionnaire Young Self Report comprises items assigned to 8 subscales describing various behavioral areas. These subscales can be summed up to scores for internalizing and externalizing problems as well as a total score.

DIAGNOSTIC_TESTphysical examination

physical development examination including height (in cm), weight (in g) and tanner states

DIAGNOSTIC_TESTmetabolic examination

metabolic development using blood analysis including blood components, metabolic parameters (Glucose, HbA1c, cholestrol)

BEHAVIORALQuestionnaire Reynolds Intellectual Assessment Scales and Screening

The RIAS is standardized intelligence test. The RIAS provides an "Total Intelligence Index" (GIX, estimate of the general intelligence/g-factor), Verbal Intelligence Index (VIX) and the Nonverbal Intelligence Index (NIX). Test scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean better cognitive performance.

DIAGNOSTIC_TESTelectroencephalogram

neurocognitive development

OTHERQuestionnaire Movement Assessment Battery for Children

The M-ABC-2 is an standardized test to assess the motoric development. Adding up subscores addressing manual dexterity, aiming and catching, and balance delivers a total score of the motoric performance. Test scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean better performance.

OTHERQuestionnaire Continuous Performance Test

The CPT measures selective attention, sustained attention as well as impulsive behavior. Checklist scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean worse performance.

OTHERQuestionnaire Diagnostic System for Mental Disorders

The FBB-ADHS assesses a total score for ADHD-like behavior and subscores for the symptom trias of ADHD (attention deficit, motoric hyperactivity as well as impulsive behavior, Questionnaire scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean higher amount of symptoms.

DIAGNOSTIC_TESTkidney function tests

urine examination (proteomics, cytokines, lipidomics)

OTHERQuestionnaire Five to Fifteen

The FTF 5-15R is a questionnaire to evaluate the child's developmental outcome in different areas of everyday life (cognition, language, and motor impairment as well as social, emotional, and behavioral problems). Individual item scores are added up per area and divided by the number of items. This results in a common scale value. Range of Percentile scores from 0 to 100 (0-90: no developmental problem; 90 and higher: hint for developmental problem). Higher scores mean worse developmental outcome.

DIAGNOSTIC_TESTcardiovacular examination

measurement of pulse wave velocity


Locations(13)

Universitäts-Frauenklinik Tübingen

Tübingen, Baden-Wurttemberg, Germany

Universitätsklinikum Ulm

Ulm, Baden-Wurttemberg, Germany

Klinikum der Universität München

München, Bavaria, Germany

Städtisches Klinikum München

München, Bavaria, Germany

Medizinische Hochschule Hannover

Hanover, Lower Saxony, Germany

Universitätsklinikum Bonn

Bonn, North Rhine-Westphalia, Germany

Universitätsklinikum Dresden

Dresden, Saxony, Germany

Uniklinikum Leipzig

Leipzig, Saxony, Germany

Krankenhaus St. Elisabeth und St. Barbara

Halle, Saxony-Anhalt, Germany

Universitätsklinikum Schleswig Holstein

Kiel, Schleswig-Holstein, Germany

Universitätsklinikum Jena

Jena, Thuringia, Germany

Berlin Charité Campus Mitte

Berlin, Germany

Berlin Vivantes Klinikum Neukölln

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06534307


Related Trials